Observational studyBMJ open2026

Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol.

Christian Domingo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.